Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $1,988 | $1,966 | $2,425 | $2,397 |
| - Cash | $760 | $360 | $480 | $749 |
| + Debt | $26 | $14 | $17 | $21 |
| Enterprise Value | $1,253 | $1,620 | $1,961 | $1,670 |
| Revenue | $1,023 | $141,706 | $128,330 | $1,078 |
| % Growth | -99.3% | 10.4% | 11,804.8% | – |
| Gross Profit | $598 | $78,971 | $542 | $628 |
| % Margin | 58.5% | 55.7% | 0.4% | 58.3% |
| EBITDA | $230 | $24,376 | $157 | $17,297 |
| % Margin | 22.5% | 17.2% | 0.1% | 1,604.6% |
| Net Income | $143 | $13,969 | $88 | $9,658 |
| % Margin | 13.9% | 9.9% | 0.1% | 895.9% |
| EPS Diluted | 0.48 | 0.32 | 0.28 | 0.27 |
| % Growth | 50% | 14.3% | 3.7% | – |
| Operating Cash Flow | $123 | $18,188 | $95 | $172 |
| Capital Expenditures | -$89 | -$13,036 | -$59 | -$38 |
| Free Cash Flow | $34 | $5,152 | $36 | $135 |